gene

RAN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about RAN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

154Connections
30Hypotheses
0Analyses
50Outgoing
50Incoming
13Experiments
0Debates

Summary

RAN is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, activates. Associated with Aging, Als, Amyotrophic Lateral Sclerosis. Connected to 73 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolRAN
Chromosome12q24.1
Amino Acids216 aa
Exons8
PathwaysEpigenetic, Notch, Circadian Rhythm, Tumor Microenvironment, Lipid Metabolism
GeneCardsRAN
Human Protein AtlasRAN
Associated DiseasesAging, Als, Amyotrophic Lateral Sclerosis, Ataxia, Dementia, frontotemporal dementia
Known Drugs/Compoundsmetformin, rapamycin
InteractionsActin, Akt, AKT, ALS, AMPK, AMYOTROPHIC LATERAL SCLEROSIS
KG Connections154 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (8)

Knowledge base pages for this entity

Canonical Page

RAN Gene

gene · 2633 words

RAN Translation in Neurodegeneration

mechanism · 2989 words

RAN GTPase Protein

protein · 1164 words

ZRANB3 — Zinc Finger RanBP2-Type Containing 3

gene · 1063 words

RANK (TNFRSF11A)

gene · 723 words

RANKL (TNFSF11)

gene · 678 words

Pathway Diagram

graph TD
    RAN["RAN"]
    Als{"Als"}
    RAN -->|"associated with"| Als
    Ms{"Ms"}
    RAN -->|"interacts with"| Ms
    Amyotrophic_Lateral_Sclerosis{"Amyotrophic Lateral Sclerosis"}
    RAN -->|"interacts with"| Amyotrophic_Lateral_Sclerosis
    Dementia{"Dementia"}
    RAN -->|"associated with"| Dementia
    Ataxia{"Ataxia"}
    RAN -->|"associated with"| Ataxia
    Huntington{"Huntington"}
    RAN -->|"associated with"| Huntington
    RAN -->|"associated with"| Ms
    RAN -->|"associated with"| Amyotrophic_Lateral_Sclerosis
    Inflammation{"Inflammation"}
    RAN -->|"inhibits"| Inflammation
    RAN -->|"regulates"| Als
    Neuroinflammation{"Neuroinflammation"}
    RAN -->|"inhibits"| Neuroinflammation
    RAN -->|"inhibits"| Amyotrophic_Lateral_Sclerosis
    C9ORF72["C9ORF72"]
    C9ORF72 -->|"interacts with"| RAN
    C9ORF72 -->|"associated with"| RAN
    P62["P62"]
    P62 -->|"inhibits"| RAN
    NOTCH3["NOTCH3"]
    NOTCH3 -->|"associated with"| RAN
    EIF2A["EIF2A"]
    EIF2A -->|"inhibits"| RAN
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    NEURODEGENERATIVE_DISEASES -->|"associated with"| RAN
    EIF2A -->|"activates"| RAN
    ATG["ATG"]
    ATG -->|"associated with"| RAN
    FTLD["FTLD"]
    FTLD -->|"contributes to"| RAN
    NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"]
    NEURODEGENERATIVE_DISORDERS -->|"associated with"| RAN
    style RAN fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (101)

TargetRelationTypeStr
Amyotrophic Lateral Sclerosisassociated_withdisease0.75
Alsassociated_withdisease0.75
ATGassociated_withgene0.70
RNAregulatesgene0.70
AMYOTROPHIC LATERAL SCLEROSISassociated_withgene0.70

Incoming (53)

SourceRelationTypeStr
C9ORF72associated_withgene0.70
ATGassociated_withgene0.70
CNBPassociated_withgene0.60
DDX3Xregulatesgene0.60
NEURODEGENERATIVE DISEASESassociated_withgene0.60

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl 0.964 neuroscience Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.958 Alzheimer's disease Circuit-level neural dynamics in neurode
Plasma NfL Elevation Secondary to BBB-Associated Transport D 0.940 - What blood-brain barrier permeability ch
Closed-loop transcranial focused ultrasound to restore hippo 0.912 Alzheimer's disease Circuit-level neural dynamics in neurode
Optimized Temporal Window for Metabolic Boosting Therapy Det 0.887 neurodegeneration How do different microglial subtypes (DA
Glymphatic-Mediated Tau Clearance Dysfunction 0.865 neuroscience Proteomics Differential Expression in AD
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima 0.862 neurodegeneration Variant Annotation and Prioritization of
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular 0.861 neuroscience TREM2 in Alzheimer's Disease: Mechanisms
H6: Aberrant eIF2α Phosphorylation Creates Stalled Translati 0.856 neurodegeneration How do pathological stress granules tran
TBK1 Loss Locks Microglia in an Aged/Senescent Transcription 0.847 ALS What are the mechanisms by which microgl
Beta-frequency entrainment therapy targeting PV interneuron- 0.846 Alzheimer's disease Circuit-level neural dynamics in neurode
miR-155/Interferon-gamma Feedback Loop as a Reversible Molec 0.843 neurodegeneration How do different microglial subtypes (DA
hnRNP A2/B1 Staufen2-Mediated Axonal RNA Granule Transport F 0.834 ALS -
IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microgl 0.831 neuroinflammation How do oligodendrocytes initiate neuroin
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign 0.827 neuroscience Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
GLE1-Mediated mRNA Export Defect Creates Translation-Compete 0.826 ALS -
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.811 neurodegeneration What are the cell-type-specific transcri
TIA1 Low-Complexity Domain Oxidation Drives Aberrant Stress 0.810 ALS -
pH-Sensitive Bispecific Antibody Targeting Transferrin Recep 0.800 neurodegeneration Blood-brain barrier antibody transport m
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.797 Alzheimer's disease Circuit-level neural dynamics in neurode
Differential Complement Regulator Expression on Synaptic Mem 0.783 synaptic biology What determines the selectivity of compl
TREM2-mediated microglial tau clearance enhancement 0.780 neurodegeneration Tau propagation mechanisms and therapeut
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic 0.780 neurodegeneration What is the therapeutic window between t
TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis 0.779 neurodegeneration What molecular mechanism causes VCP muta
Closed-loop transcranial focused ultrasound to restore hippo 0.773 Alzheimer's disease Circuit-level neural dynamics in neurode
Inhibiting Heparan Sulfate Proteoglycan Receptor-Mediated Ne 0.772 neuroscience Trans-synaptic tau spreading and propaga
Lysosomal Cathepsin-Dependent Tau Clearance 0.767 neurodegeneration View
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T 0.000 ALS What are the mechanisms by which microgl

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (13)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn clinical Alzheimer's disease and relate 0.950 0.00 human patients proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Differential GWAS of schizophrenia vs PTSD exploratory schizophrenia, post-traumatic 0.900 0.00 human patients - European ance proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Creation and validation of 3xAD-ChAT-Cre mouse model validation Alzheimer's disease 0.900 0.00 3xAD-ChAT-Cre transgenic mice proposed N/A
NAD depletion effects on monocyte/macrophage differentiation exploratory Inflammatory bowel disease 0.900 0.00 Primary mouse and human monocy proposed N/A
FK866 treatment in DSS-induced colitis mouse model validation Inflammatory bowel disease (co 0.900 0.00 DSS-induced colitis mice proposed N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus exploratory schizophrenia, post-traumatic 0.850 0.00 human brain tissue samples fro proposed N/A
FK866 in azoxymethane/DSS colitis-associated cancer model validation Colitis-associated cancer 0.850 0.00 AOM/DSS-treated mice proposed N/A
FK866 mechanism validation in Rag1-/- mice validation Inflammatory bowel disease 0.850 0.00 Rag1-/- mice with DSS-induced proposed N/A
PERK Inhibitor GSK2606414 + GADD34 Mimetic Sephin1 Rescues eIF2alpha S in_vitro ALS / FTD 0.830 0.85 iPSC-derived motor neurons fro proposed $67,000
Microtubule domain analysis in adult axons exploratory 0.800 0.00 adult rodent axons proposed N/A
Tau depletion effects on microtubule domains in adult axons exploratory 0.800 0.00 adult rodent neurons proposed N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
Mapping the Brain's Glymphatic System. [PMID:41751308] Voumvourakis K, Thomaidis NS, Tsiodras S Biomedicines 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Melatonin Mitigates Sleep Restriction-Induced Cognitive and Glymphatic Dysfuncti [PMID:40293704] Sun H, Cao Q, He X, Du X, Jiang X, Wu T, Molecular neurobiology 2025 0
Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Thera [PMID:40922457] ["Eroglu E", "Harmanci N"] Basic & clinical pharmacology 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Clearance mechanisms of the glymphatic/lymphatic system in the brain: new therap [PMID:41376656] He Z, Sun J Cognitive neurodynamics 2025 0
Glymphatic and meningeal lymphatic dysfunction in Alzheimer's disease: Mechanism [PMID:41152198] Ding J, Zhao C, Hao X, Jiao H Alzheimer's & dementia : the j 2025 0
When sleep fails, brain clearance suffers: the role of glymphatic impairment in [PMID:41315137] ["De la Herr\u00e1n-Arita Alberto K"] Acta neurologica Belgica 2025 0
Calcium release from damaged lysosomes triggers stress granule formation for cel [PMID:39962896] Jayabalan AK, Ayeni A, Jia J Autophagy 2025 0
Integrated stress response inhibition prolongs the lifespan of a Pelizaeus-Merzb [PMID:41453885] Chen Y, Kunjamma RB, Lin K Nat Commun 2025 0
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] Zhang D, Zhang W, Ming C, Gao X, Yuan H, Neuron 2024 0
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] Balusu S, De Strooper B Acta neuropathologica 2024 0
Oligodendrocyte-selective deletion of the eIF2α kinase Perk/Eif2ak3 limits funct [PMID:38587137] Saraswat Ohri S, Forston MD, Myers SA Glia 2024 0
Neuropathology of incidental Lewy body & prodromal Parkinson's disease. [PMID:37173733] Koeglsperger T, Rumpf SL, Schließer P, S Molecular neurodegeneration 2023 0
Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurod [PMID:33603230] Dong Y, D'Mello C, Pinsky W, Lozinski BM Nature neuroscience 2021 0
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] Burillo J, Marqués P, Jiménez B, Gonzále Cells 2021 0
WDR45 contributes to neurodegeneration through regulation of ER homeostasis and [PMID:31204559] ["Wan Huida", "Wang Qi", "Chen Xiuting", Autophagy 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning RAN in their description or question text

Glymphatic-Mediated Tau Clearance Dysfunction

Score: 0.865 · neuroscience · 2026-04-07

## Mechanistic Overview Glymphatic-Mediated Tau Clearance Dysfunction starts from the claim that modulating MAPT within

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Faile

Score: 0.862 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance

Score: 0.861 · neuroscience · 2026-04-12

## Mechanistic Overview TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance starts from the claim

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

Score: 0.856 · neurodegeneration · 2026-04-22

## Mechanistic Overview H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State starts from the claim that

TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fueling AL

Score: 0.847 · ALS · 2026-04-26

The hypothesis proposes that loss-of-function mutations in TBK1 contribute to ALS pathogenesis by trapping microglia in

Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling f

Score: 0.846 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance

miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Prot

Score: 0.843 · neurodegeneration · 2026-04-16

## Mechanistic Overview miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Protective Microglia

IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microglia Interface

Score: 0.831 · neuroinflammation · 2026-04-13

## Mechanistic Overview IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microglia Interface starts from the claim t

Microglial-Mediated Tau Clearance Dysfunction via TREM2 Signaling

Score: 0.827 · neuroscience · 2026-04-07

## Mechanistic Overview Microglial-Mediated Tau Clearance Dysfunction via TREM2 Signaling starts from the claim that mod

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.827 · Alzheimer's disease · 2026-04-16

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST inter

Score: 0.827 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to resto

CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerabilit

Score: 0.811 · neurodegeneration · 2026-04-16

## Mechanistic Overview CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerability Thresholds sta